The pyruvate-GPR31 axis promotes transepithelial dendrite formation in human intestinal dendritic cells.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
29 Oct 2024
Historique:
medline: 22 10 2024
pubmed: 21 10 2024
entrez: 21 10 2024
Statut: ppublish

Résumé

The intestinal lumen is rich in gut microbial metabolites that serve as signaling molecules for gut immune cells. G-protein-coupled receptors (GPCRs) sense metabolites and can act as key mediators that translate gut luminal signals into host immune responses. However, the impacts of gut microbe-GPCR interactions on human physiology have not been fully elucidated. Here, we show that GPR31, which is activated by the gut bacterial metabolite pyruvate, is specifically expressed on type 1 conventional dendritic cells (cDC1s) in the lamina propria of the human intestine. Using human induced pluripotent stem cell-derived cDC1s and a monolayer human gut organoid coculture system, we show that cDC1s extend their dendrites toward pyruvate on the luminal side, forming transepithelial dendrites (TED). Accordingly, GPR31 activation via pyruvate enhances the fundamental function of cDC1 by allowing efficient uptake of gut luminal antigens, such as dietary compounds and bacterial particles through TED formation. Our results highlight the role of GPCRs in tuning the human gut immune system according to local metabolic cues.

Identifiants

pubmed: 39432783
doi: 10.1073/pnas.2318767121
doi:

Substances chimiques

Receptors, G-Protein-Coupled 0
Pyruvic Acid 8558G7RUTR

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2318767121

Subventions

Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP21H050430
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP21K07895
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP21gm1010004
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JPMJSP213
Organisme : BD Biosciences (Becton Dickenson Biosciences)
ID : J178501002

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Eri Oguro-Igashira (E)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
World Premier International Research Center Initiative (WPI) Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan.
Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.

Mari Murakami (M)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
World Premier International Research Center Initiative (WPI) Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan.

Ryota Mori (R)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.

Ryuichi Kuwahara (R)

Department of Gastroenterological Surgery, Division of Inflammatory Bowel Disease Surgery, Hyogo Medical University, Hyogo 663-8501, Japan.

Takako Kihara (T)

Department of Surgical Pathology, Hyogo Medical University, Hyogo 663-8501, Japan.

Masaharu Kohara (M)

Department of Pathology, Osaka University Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.

Makoto Fujiwara (M)

Department of Pediatrics, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.

Daisuke Motooka (D)

World Premier International Research Center Initiative (WPI) Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan.
Department of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka 565-0871, Japan.

Daisuke Okuzaki (D)

World Premier International Research Center Initiative (WPI) Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan.
Department of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka 565-0871, Japan.
Division of Microbiology and Immunology, Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.
Center for Advanced Modalities and Drug Delivery System, Osaka University, Osaka 565-0871, Japan.

Mitsuru Arase (M)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
World Premier International Research Center Initiative (WPI) Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan.

Hironobu Toyota (H)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.

Siyun Peng (S)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
World Premier International Research Center Initiative (WPI) Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan.

Takayuki Ogino (T)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.

Yasuji Kitabatake (Y)

Department of Pediatrics, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.

Eiichi Morii (E)

Department of Pathology, Osaka University Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.

Seiichi Hirota (S)

Department of Surgical Pathology, Hyogo Medical University, Hyogo 663-8501, Japan.

Hiroki Ikeuchi (H)

Department of Gastroenterological Surgery, Division of Inflammatory Bowel Disease Surgery, Hyogo Medical University, Hyogo 663-8501, Japan.

Eiji Umemoto (E)

Laboratory of Microbiology and Immunology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.

Atsushi Kumanogoh (A)

Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka 565-0871, Japan.
Division of Microbiology and Immunology, Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.
Center for Advanced Modalities and Drug Delivery System, Osaka University, Osaka 565-0871, Japan.
Department of Immunopathology, World Premier International Research Center Initiative (WPI) Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan.

Kiyoshi Takeda (K)

Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
World Premier International Research Center Initiative (WPI) Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka 565-0871, Japan.
Division of Microbiology and Immunology, Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH